CC Diagnostics aims to market a superior method for diagnosing early stages of cervical cancer. With this accurate test implemented in national cervical cancer screening programs (or sold on the private market), a big part of unneeded follow-up diagnostic can be prevented. As a result, healthcare costs and women’s stress will be reduced. With this method of testing, CC Diagnostics can play its part in making sure there is accurate and participative cervical screening available for every woman.